Clinical Trials Directory

Trials / Completed

CompletedNCT02589392

Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis

Effect of Cetaphil® Restoraderm® Moisturizer on Very Dry Skin in Children With a Controlled Atopic Dermatitis:a Randomised, Parallel Group Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
2 Years – 12 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of Cetaphil® Restoraderm® skin restoring moisturizer in reducing the signs and symptoms of very dry atopic skin in young children. Subjects with atopic dermatitis (AD) in remission phase will be randomized to receive either Cetaphil® Restoraderm® skin restoring body wash only, or the same body wash in association with Cetaphil® Restoraderm® skin restoring moisturizer.

Detailed description

Two groups randomized in a ratio of \[1:1\] for a 12-week period Five study evaluation were planned: at Baseline, week 2, Week 4, Week8 and Week12

Conditions

Interventions

TypeNameDescription
OTHERCetaphil® Restoraderm® moisturizer + Cetaphil® Restoraderm® body wash
OTHERCetaphil® Restoraderm® body wash

Timeline

Start date
2015-05-29
Primary completion
2016-02-03
Completion
2016-02-03
First posted
2015-10-28
Last updated
2024-02-26
Results posted
2024-02-26

Locations

8 sites across 2 countries: China, Philippines

Source: ClinicalTrials.gov record NCT02589392. Inclusion in this directory is not an endorsement.